An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD-Reference-Cited by-同舟云学术

An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD

Published:2021-12 Issue: Volume: Page:
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Lim Grace En Hui,Tang Ansel,Ng Cheng Han,Chin Yip Han,Lim Wen Hui,Tan Darren Jun Hao,Yong Jie Ning,Xiao Jieling,Lee Chloe Wen-Min,Chan Mark,Chew Nicholas WS.,Xuan Tan Eunice Xiang,Siddiqui Mohammad Shadab,Huang Daniel,Noureddin Mazen,Sanyal Arun J.,Muthiah Mark D.^ORCID

Funder

Bristol-Myers Squibb

Gilead Sciences

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference62 articles.

1. Non-alcoholic fatty liver disease;Powell;Lancet,2021

2. EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

3. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases;Chalasani;Hepatology,2018

4. A clinical overview of NAFLD: a guide to diagnosis, the clinical features, and complications – what the non-specialist needs to know;Muthiah;Diabetes Obes Metab,2021

5. Nonalcoholic steatohepatitis: a review;Sheka;JAMA,2020

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between the traditional Chinese medicine constitution and metabolic dysfunction-associated fatty liver disease in older people: A cross-sectional study;Heliyon;2024-02

2. Assessment of endocrine disruptor impacts on lipid metabolism in a fatty acid-supplemented HepaRG human hepatic cell line;Chemosphere;2024-02

3. Associations of polychlorinated biphenyls and organochlorine pesticides with metabolic dysfunction-associated fatty liver disease among Chinese adults: Effect modification by lifestyle;Environmental Research;2024-01

4. Calenduloside E ameliorates non-alcoholic fatty liver disease via modulating a pyroptosis-dependent pathway.;Journal of Ethnopharmacology;2024-01

5. Association of Uric Acid to Creatinine Ratio with Metabolic Dysfunction-Associated Fatty Liver in Non-Obese Individuals Without Type 2 Diabetes Mellitus;Diabetes, Metabolic Syndrome and Obesity;2024-01